Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04974619
Other study ID # MCC-20819
Secondary ID U54CA163068U54CA
Status Completed
Phase
First received
Last updated
Start date July 23, 2021
Est. completion date August 30, 2022

Study information

Verified date June 2024
Source H. Lee Moffitt Cancer Center and Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of the study is to assess Human Papillomavirus (HPV) and HPV vaccination knowledge, awareness, attitudes, health beliefs, and behaviors as well as educational preferences for learning more about HPV and HPV vaccination and to receive feedback on and adapt HPV educational materials for Young Latino Men who have Sex with Men (YLMSM).


Description:

To assess HPV and HPV vaccination knowledge, awareness, attitudes, health beliefs, and behaviors as well as educational preferences among 260 Spanish-speaking YLMSM ages 18-26 in Florida and Puerto Rico. To conduct 20 in-depth interviews with key stakeholders (10 in PR and 10 in FL) eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation. To culturally adapt an existing Cancer 101 educational resource in English and Spanish for YLMSM ages 18-26 and to conduct focus groups or individual interviews with 24 YLMSM in PR (n=12) and FL (n=12) to gain feedback on the acceptability, accessibility, content, delivery preferences, and aesthetics of the theoretically informed, HPV educational intervention targeted for English and/or Spanish-speaking YLMSM.


Recruitment information / eligibility

Status Completed
Enrollment 155
Est. completion date August 30, 2022
Est. primary completion date August 30, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria for Aim 1 & 3: - Men who have had sex with a man and/or are attracted to men - Hispanic/Latino ethnicity - Able to read, write and understand Spanish (for Aim 1) and Spanish or English (for Aim 3) - Aged 18-26 years - Primary residence in either Puerto Rico or Florida - Has access to the internet (Aim 1 only) Additional criteria for Aim 3: - Has regular access to a working telephone or be able to attend an in-person focus group (modifications related to COVID-19 situation will allow virtual modality to complete the focus groups or individual interviews). - Able to read, write and understand Spanish or English Inclusion Criteria for Aim 2: - Individuals with a current or prior role (within last twelve months) in a community-based organization, private or public healthcare clinic, health department, college/university organization, or interest group that provides services to sexual minorities in FL or PR as a healthcare provider, staff member, group member, or in a leadership role - Age 21 or older - Able to understand, read and speak either Spanish or English - Access to a working telephone or computer Exclusion Criteria for Aim 1 & 3: - Self identifies as either transman or transwoman - aged <18 years or >27 years - Individuals who contact the research team about interest in participating on Aims 1 or 3 (when recruitment cap has been completed for that aim) can be directed to Aims 1 or 3 for possible recruitment. Individuals can participate in more than 1 aim, but not more than one time in a single aim.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Online survey
Aim 1 Participants will be asked to complete a Qualtrics survey to identify knowledge gaps, health beliefs, attitudes, and educational learning preferences.
Focus groups or Individual Interviews
Focus groups and/or individual interviews will be conducted in-person and/or remotely to receive feedback on the HPV vaccine education materials. Focus groups and/or individual interviews will be conducted with 24 young adult Latino men who have sex with men (YLMSM) in either English or Spanish (approximately 12 in Puerto Rico and approximately 12 in Florida). The purpose will be to gain feedback on the acceptability, accessibility, content, delivery preference, and aesthetics of the theoretically informed HPV education materials culturally targeted for Spanish- and/or English-speaking YLMSM.
Interviews
In-depth interviews (n=20) will be conducted with key stakeholders (10 in PR and 10 in FL) eliciting feedback to inform intervention content and delivery methods and identify potential facilitators and barriers to intervention implementation.

Locations

Country Name City State
Puerto Rico Ponce Health Sciences University Ponce
United States Moffitt Cancer Center Tampa Florida

Sponsors (2)

Lead Sponsor Collaborator
H. Lee Moffitt Cancer Center and Research Institute National Cancer Institute (NCI)

Countries where clinical trial is conducted

United States,  Puerto Rico, 

Outcome

Type Measure Description Time frame Safety issue
Primary Part 1: HPV Vaccine Knowledge (Aim 1) A scale consisting of 19 items (Score range 0-18) assessing general HPV knowledge and 9 items (Score range 0-9) assessing HPV vaccination-specific knowledge (modified from scales by Perez et al 2016 and Waller et al 2013, respectively), using a response scale consisting of True, False, and I don't know; higher scores mean higher knowledge. Day 1
Primary Part 1: HPV Vaccine Awareness (Aim 1) A scale consisting of 2 items from the Health Information National Trends Survey (HINTS) 2018, with response options Yes or No; Positive responses mean higher awareness Day 1
Primary Part 1: HPV Vaccine Attitude (Aim 1) A scale consisting of 8 items modified from the Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS); with a 5-point response scale ranging from strongly disagree to strongly agree; higher scores mean stronger attitudes. The possible scale score range = 8-40. Day 1
Primary Part 1: HPV Vaccine Health Beliefs 1 (Aim 1) Participants will complete scales; a. Perceived Risk 5 point scale from no chance to Certain I will get; higher scores mean higher perceived risk; b. Descriptive norms scale from 0% to 100%, higher score mean greater descriptive norms; c. Perceived norms 8 point scale ranging from strongly disagree to strongly agree, not applicable, higher scores mean stronger perceived norms; d. Perceived Barriers 3-point scale ranging from Not concerned at all to Very concerned, higher scores mean higher perceived barriers; e. Self-efficacy scale ranging from Strongly agree to Strongly Disagree; lower scores mean higher self-efficacy. Day 1
Primary Part 1: HPV Vaccine Health Beliefs 2 (Aim 1) Count of participants who responded what they thought their perceived risk is contracting HPV. Questions range from Much below average, below average, average risk, above average risk, much above average risk, and I don't know. Day 1
Primary Part 1: HPV Vaccine Health Beliefs 3 (Aim 1) Count of participants who responded within each category asking intention to get HPV vaccine among those unvaccinated, using a 7-point scale ranging from Very unlikely to Very likely, higher scores mean stronger intentions. Day 1
Primary Part 1: HPV Vaccine Behaviors 1 (Aim 1) Count of participants who responded within each category that assesses past receipt of the HPV vaccine (modified from Brewer et al., 2009 and Brewer et al., 2017). Responses were: Yes, No, I don't know. Day 1
Primary Part 1: HPV Vaccine Behaviors 2 (Aim 1) Count of participants that self reported number of shots received among vaccinated individuals. Items range from 1 shot to I don't know. Day 1
Primary Part 1: HPV Vaccine Educational Preferences 1 (Aim 1) A scale developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, "Who would you like to receive information from?". Options were Physician, Other healthcare provider (Nurse, Medical Assistant), Female peer, Male peer, Parent of teen, Parent of young adult, Someone who has survived an HPV-related Cancer Other. Participants marked all that applied. Day 1
Primary Part 1: HPV Vaccine Educational Preferences 2 (Aim 1) Items developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, "Best method for delivering education?". 1 being the best method and 8 being the worst method. Day 1
Primary Part 1: HPV Vaccine Educational Preferences 3 (Aim 1) An item developed by Christy (unpublished) assessing HPV vaccine education preferences. The survey question, "What age would it be most helpful to for a person to receive educational information?" Day 1
Primary Part 2: Facilitators and Barriers to Intervention Implementation (Aim 2) Number of participants who consented and participated in individual interviews. Day 1
Primary Part 3: Feedback From Focus Groups or Individual Interviews (Aim 3) Number of Participants who completed either an individual interview or participated in a focus group. Day 1
See also
  Status Clinical Trial Phase
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Completed NCT01105000 - Human Papilloma Virus (HPV) Knowledge and Attitudes and the Role of (SES) Socioeconomic Status and Ethnicity
Recruiting NCT06147388 - Regression of Cervical Precancerous Lesions and Associated Risk Factors
Recruiting NCT04708470 - A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers Phase 1/Phase 2
Recruiting NCT06109870 - Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening N/A
Completed NCT03082950 - HPV Infections, Cancer of the Vulva and Therapeutical Success
Recruiting NCT01512784 - Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults Phase 3
Recruiting NCT05363709 - BALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients Phase 2
Completed NCT01231945 - Low-Cost Molecular Cervical Cancer Screening Study N/A
Recruiting NCT01011712 - The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
Recruiting NCT05996016 - Gut and Vaginal Microbiota Profile Study for HIV Women
Completed NCT05907187 - Research in Ethno-Medicine and Education (REMED) N/A
Completed NCT05616767 - Prevention and Screening for Early Detection of HPV-related Cancers in Gay and Bisexual Men in Tanzania N/A
Completed NCT02247999 - Improving Cervical Cancer Screening Among HIV-Infected Women in India
Terminated NCT01468636 - A RTC to Examine the Effectiveness of 400 mg of Oral Zinc Gluconate as Adjunctive Therapy for Ano-genital Warts Phase 4
Active, not recruiting NCT04965792 - Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Active, not recruiting NCT05006833 - Text and Talk: A Multi-level Intervention to Increase Provider HPV Vaccine Recommendation Effectiveness N/A
Enrolling by invitation NCT06120205 - SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening N/A
Recruiting NCT05208710 - PANHPVAX, Study of a New HPV Vaccine in Healthy Volunteers Early Phase 1
Completed NCT05462249 - Impact of Catch-up HPV Vaccination